Hormonal, lipoprotein, and vascular effects of the selective estrogen receptor modulator raloxifene in hypercholesterolemic men

American Journal of Cardiology

Volumn 85, Issue 12, 2000, Pages 1491-1494

  Blum, Arnon ^a   Hathaway, Londa ^a   Mincemoyer, Rita ^a   Schenke, William H ^a   Csako, Gyorgy ^b   Waclawiw, Myron A ^a   Panza, Julio A ^a   Cannon III, Richard O ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; RALOXIFENE;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; HORMONAL THERAPY; HUMAN; HYPERCHOLESTEROLEMIA; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

CELL ADHESION MOLECULES; GONADAL STEROID HORMONES; GONADOTROPINS, PITUITARY; HUMANS; HYPERCHOLESTEROLEMIA; LIPIDS; MALE; MIDDLE AGED; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATORS; VASODILATION;

EID: 0034660165     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(00)00802-X     Document Type: Article

References (20)

1. Stampfer M.J., Colditz G.A., Willett W.C., Manson J.E., Rosner B., Speizer F.E., Hennekens C.H. Postmenopausal estrogen therapy and cardiovascular disease ten-year follow-up from the Nurses' Health Study . N Engl J Med. 325:1991;756-762.
2. Collins P., Rosano G.M.C., Sarrel P.M., Ulrich L., Adamopoulos S., Beale C.M., McNeill J.G., Poole-Wilson P.A. 17-beta-estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation. 92:1995;24-30.
3. Reis S.E., Holubkov R., Zell K.A., Smith A.J., Cohen H.A., Feldman M.D., Blumenthal R.S. Estrogen acutely abolishes abnormal cold-induced coronary constriction in men. Chest. 114:1998;1556-1561.
4. Reis S.E., Bhoopalam V., Zell K.A., Counihan P.J., Smith A.J., Pham S., Murali S. Conjugated estrogens acutely abolish abnormal cold-induced coronary vasoconstriction in male cardiac allografts. Circulation. 97:1998;23-25.
5. McCrohon J.A., Walters W.A., Robinson J.T., McCredie R.J., Turner L., Adams M.R., Handelsman D.J., Celermajer D.S. Arterial reactivity is enhanced in genetic males taking high dose estrogens. J Am Coll Cardiol. 29:1997;1432-1436.
6. New G., Timmins K.L., Duffy S.J., Tran B.T., O'Brien R.C., Harper R.W., Meredith I.T. Long-term estrogen therapy improves vascular function in male to female transsexuals. J Am Coll Cardiol. 29:1997;1437-1444.
7. Weiner C.P., Lizasoain I., Baylis S.A., Knowles R.G., Charles I.G., Moncada S. Induction of calcium-dependent nitric oxide synthase activity by sex hormones. Proc Natl Acad Sci USA. 91:1994;5212-5216.
8. The Coronary Drug Project. JAMA. 226:1973;652-657.
9. Damewood M.D., Bellantoni J.J., Bachorik P.S., Kimball A.W. Jr, Rock J.A. Exogenous estrogen effect on lipid/lipoprotein cholesterol in transsexual males. J Endocrinol Invest. 12:1989;449-454.
10. Walsh B.W., Kuller L.H., Wild R.A., Paul S., Farmer M., Lawrence J.B., Shah A.S., Anderson P.W. Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women. JAMA. 279:1998;1445-1451.
11. White J.W. Jr. Relative significance of dietary sources of nitrate and nitrite. J Agric Food Chem. 23:1975;886-889.
12. Celermajer D.S., Sorensen K.E., Gooch V.M., Spiegelhalter D.J., Miller O.I., Sullivan I.D., Lloyd J.K., Deanfield J.E. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 340:1992;1111-1115.
13. De Caterina R., Libby P., Peng H.B., Thannickal V.J., Rajavashisth T.B., Gimbrone M.A. Jr, Shin W.S., Liao J.K. Nitric oxide decreases cytokine-induced activation nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines . J Clin Invest. 96:1995;60-68.
14. Williams J.K., Honore E.K., Adams M.R. Contrasting effects of conjugated estrogens and tamoxifen on dilator responses of atherosclerotic epicardial coronary arteries in nonhuman primates. Circulation. 96:1997;1970-1975.
15. Gooren L.J. Human male sexual functions do not require aromatization of testosterone A study using tamoxifen, testolactone, and dihydrotestosterone . Arch Sex Behav. 14:1985;539-547.
16. Webb C.M., McNeill J.G., Hayward C.S., de Zeigler D., Collins P. Effects of testosterone on coronary vasomotor regulation in men with coronary artery disease. Circulation. 100:1999;1690-1696.
17. Rosano G.M.C., Leonardo F., Pagnotta P., Pelliccia F., Panina G., Cerquetani E., della Monica P.L., Bonfigli B., Volpe M., Chierchia S.L. Acute anti-ischemic effect of testosterone in men with coronary artery disease. Circulation. 99:1999;1666-1670.
18. Herman S.M., Robinson J.T., McCredie R.J., Adams M.R., Boyer M.J., Celermajer D.S. Androgen deprivation is associated with enhanced endothelium-dependent dilation in adult men. Arterioscler Thromb Vasc Biol. 17:1997;2004-2009.
19. Shepard J., Cobbe S.M., Ford I., Isles C.G., Lorimer A.R., Macfarlane P.W., McKillop J.H., Packard C.J. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med. 333:1995;1301-1307.
20. Downs J.R., Clearfield M., Weis S., Whitney E., Shapiro D.R., Beere P.A., Langendorfer A., Stein E.A., Kruyer W., Gotto A.M. Jr. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study . JAMA. 279:1998;1615-1622.